FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler
Links shared publicly online about this topic.
- 1,456total visits
FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler
fda.gov —
The u.s. food and drug administration today announced that data from a recent review of the spiriva handihaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (copd), do not support an increased risk of stroke, heart attack, or death in patients using the medicine.
View full resource at fda.gov
Tags: Stroke, COPD, COPD Medication, Disease and Condition, Drug, FDA, Spiriva, Pulmonology
Most Recently Shared on January 14, 2010 at 8:44 pm By:
FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler http://ow.ly/Wz3t
Also Shared By:
FDA Updates Earlier Guidance On Respiratory Treatment Spiriva HandiHaler
medicalnewstoday.com — “The u.s. food and drug administration announced that data from a recent review of the spiriva handihaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (copd), do n” View full resource at medicalnewstoday.com
Most Recently Shared on January 15, 2010 at 2:08 pm By:
MNT Medical Devices Health News
FDA Updates Earlier Guidance On Respiratory Treatment Spiriva HandiHaler http://mnt.to/3wmD
Advertisement
Rich Meyer
@richmeyer
FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler http://bit.ly/8RuxQm
1 year ago...